ADHD stimulants and their effect on height in children

Canadian Family Physician

Volumn 56, Issue 2, 2010, Pages 145-146

  Goldman, Ran D ^a  

^a PRETx Program   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; DOPAMINE; GROWTH HORMONE; METHYLPHENIDATE;

ACADEMIC ACHIEVEMENT; APPETITE; ATTENTION DEFICIT DISORDER; BODY HEIGHT; CHILD GROWTH; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GENERAL PRACTITIONER; GROWTH HORMONE RELEASE; GROWTH INHIBITION; HUMAN; PATIENT MONITORING; PRESCRIPTION; SHORT SURVEY;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; GROWTH; HUMANS;

EID: 77649298434     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Schmidt S, Petermann F. Developmental psychopathology: attention deficit hyperactivity disorder (ADHD). BMC Psychiatry 2009;9:58.
2. Wigal SB. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs 2009;23(Suppl 1):21-31.
3. Fletcher J, Wolfe B. Long-term consequences of childhood ADHD on criminal activities. J Ment Health Policy Econ 2009;12(3):119-38.
4. Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, et al. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Ann Pharmacother 2009;43(6):1084-95. Epub 2009 May 26.
5. Vitiello B. Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. Child Adolesc Psychiatr Clin N Am 2008;17(2):459-74, xi.
6. Warren AE, Hamilton RM, Bélanger SA, Gray C, Gow RM, Sanatani S, et al. Cardiac risk assessment before the use of stimulant medications in children and youth: a joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry. Can J Cardiol 2009;25(11):625-30.
7. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997;100(4):662-6.
8. Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47(9):994-1009.
9. Safer DJ, Allen RP, Barr E. Growth rebound after termination of stimulant drugs. J Pediatr 1975;86(1):113-6.
10. Klein RG, Landa B, Mattes JA, Klein DF. Methylphenidate and growth in hyperactive children. A controlled withdrawal study. Arch Gen Psychiatry 1988;45(12):1127-30.